Skip to main content

Table 2 Overview of the sMR concentrations in the different groups of patients with invasive fungal infections

From: The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT

 

Number of patients

sMR (mg/L) (median and IQR)

Proven invasive aspergillosis

9

1.20 (0.57–1.51)

Probable invasive aspergillosis

10

0.78 (0.66–1.06)

Other filamentary fungi

2

0.82 (0.63–1.01)

Candida blood stream infection

24

1.14 (0.67–1.81)

Invasive candidiasis (abdominal, pleural or mediastinal)

37

0.84 (0.59–1.08)

  1. sMR soluble mannose receptor, IQR interquartile range